Levofloxacin chemical structure
Find information on thousands of medical conditions and prescription drugs.

Levaquin

Levofloxacin is a fluoroquinolone antibiotic, marketed by Ortho-McNeil under the brand name Levaquin. Chemically, levofloxacin is the S-enantiomer (L-isomer) of ofloxacin. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
Labetalol
Lacrisert
Lactitol
Lactuca virosa
Lactulose
Lamictal
Lamisil
Lamivudine
Lamotrigine
Lanophyllin
Lansoprazole
Lantus
Lariam
Larotid
Lasix
Latanoprost
Lescol
Letrozole
Leucine
Leucovorin
Leukeran
Levaquin
Levetiracetam
Levitra
Levocabastine
Levocetirizine
Levodopa
Levofloxacin
Levomenol
Levomepromazine
Levonorgestrel
Levonorgestrel
Levophed
Levora
Levothyroxine sodium
Levoxyl
Levulan
Lexapro
Lexiva
Librium
Lidocaine
Lidopen
Linezolid
Liothyronine
Liothyronine Sodium
Lipidil
Lipitor
Lisinopril
Lithane
Lithobid
Lithonate
Lithostat
Lithotabs
Livostin
Lodine
Loestrin
Lomotil
Loperamide
Lopressor
Loracarbef
Loratadine
Loratadine
Lorazepam
Lortab
Losartan
Lotensin
Lotrel
Lotronex
Lotusate
Lovastatin
Lovenox
Loxapine
LSD
Ludiomil
Lufenuron
Lupron
Lutropin alfa
Luvox
Luxiq
Theophylline
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Levofloxacin is effective against a number of gram-positive and gram-negative bacteria. Because of its broad spectrum of action, levofloxacin is frequently prescribed empirically for a wide range of infections (e.g. pneumonia, urinary tract infection) before the specific causal organism is known. If the causal organism is identified, levofloxacin is sometimes discontinued and the patient may be switched to an antibiotic with a narrower spectrum

Gram-positive bacteria

  • Enterococcus faecalis (many strains are only moderately susceptible)
  • Staphylococcus aureus (methicillin-susceptible strains)
  • Staphylococcus epidermidis (methicillin-susceptible strains)
  • Staphylococcus saprophyticus
  • Streptococcus pneumoniae (including penicillin-resistant strains*)
  • Streptococcus pyogenes

Levofloxacin only has moderate Gram-positive coverage; beta-lactams (e.g. ceftriaxone) or glycopeptides (e.g. vancomycin) are generally preferred for this indication.

Gram-negative bacteria

  • Enterobacter cloacae
  • Klebsiella pneumoniae
  • Pseudomonas aeruginosa
  • Escherichia coli
  • Legionella pneumophila
  • Serratia marcescens
  • Haemophilus influenzae
  • Moraxella catarrhalis
  • Haemophilus parainfluenzae
  • Proteus mirabilis
  • Campylobacter

Other

  • Chlamydia pneumoniae
  • Mycoplasma pneumoniae

Some information extracted from Levaquin Prescribing information.

Read more at Wikipedia.org


[List your site here Free!]


A case of pulmonary tuberculosis and miliary sarcoidosis
From CHEST, 10/1/05 by Marilyn Y. Kline

INTRODUCTION: A miliary pattern of pulmonary sarcoid is rare and in fact, is difficult to distinguish from miliary tuberculosis. Similarly, bone involvement in sarcoid is infrequent and can be overlooked. We present a patient with known tuberculosis and disseminated sarcoid including involvement of the spleen, liver, and bone, and presenting in the lung as miliary disease.

CASE PRESENTATION: This is a case of a 53-year-old female with an established diagnosis of tuberculosis on treatment. The patient is a citizen of panama (who appears African-Carribean) and came to the U.S. in May 2004. She had no other medical history and had a recent normal pap smear and mammogram. She is a never smoker, uses rare alcohol and never used IV drugs. She works in a clothing factory as a clerk, has no known occupational exposures, and is HIV negative. In April she was diagnosed with sputum culture positive pansensitive tuberculosis and was started on INH, rifampin, pyrazinamide, and ethambutol. Chest radiograph revealed a left basilar infiltrate and miliary disease. In May, the patient developed hepatic failure thought secondary to the tuberculosis medications and was admitted to an outside hospital. The patient was discharged on streptomycin, levaquin, and ethambutol; sputums were AFB culture negative. Six weeks after the initiation of this regimen, the patient complained of dizziness. The patient was admitted to the Bellevue Hospital Chest Service in October for evaluation of her dizziness which had then been of 4 1/2 months duration. Tuberculosis medications were held. Neurologic exam was non-focal. Chest radiograph showed multiple small nodules unchanged from June, and resolution of the left infiltrate. A chest CT showed diffuse perilymphatic small (<1cm), well-defined, non-calcified, mainly non-cavitating nodules bilaterally, left basilar scarring and was interpreted as likely metastatic cancer. No effusions or adenopathy was noted. An abdominal CT scan noted a lesion in the liver, and diffuse granulomatous-type infiltration of the liver and spleen. Osseus lucencies suggestive of bone metastases were noted. A bone scan revealed uptake in the right femoral neck, T8 vertebra, and the calvarium. A brain MRI revealed multiple metastatic appearing lesions in the calvarium. A malignancy work-up ensued. The liver was biopsied with a cytopathology needle revealing non-necrotizing granulomatous inflammation and no malignancy. AFB was negative. A bronchoscopy was similarly unrevealing and AFB was negative. In January, rifabutin and isoniazid were restarted. The patient refused open-lung biopsy. A calvarial biopsy was performed revealing multiple non-caseating granulomas and no malignant cells. Cultures, including AFB, were negative. An ACE level was elevated at 160.

DISCUSSIONS: We diagnosed the patient with sarcoidosis, steroids have been started. There is some resolution of the patient's pulmonary nodules. The dizziness, which may be a cranial nerve dysfunction related to sarcoid, has diminished slightly. Follow-up imaging of the bone, liver and spleen involvment is planned.

CONCLUSION: We present an unusual case of concurrent tuberculosis and sarcoidosis, including a miliary pulmonary pattern without adenopathy, bone, diffuse liver and spleen involvement and possibly cranial nerve VIII dysfunction. This patient was initially misdiagnosed with miliary TB and later worked up for cancer. Miliary TB typically presents with multiple, small (1-5 mm) nodules that are randomly positioned in the parenchyma, and along the pleura and fissures. Miliary tuberculosis represents 1-3% of all tuberculosis cases. A miliary presentation of sarcoidosis is rare and can be very difficult to distinguish from tuberculosis and malignancy. The overall frequency of bone involvement in sarcoid is about 3% and is generally asymptomatic. The short bones of the hands and feet are usually involved while the long bones, and vertebrae are rarely involved.

REFERENCE:

(1) Fraser, Richard S, et al; Diagnosis of Diseases of the Chest, Fourth Edition. Vol 3. 1551-1563.

DISCLOSURE: Marilyn Kline, None.

Marilyn Y. Kline MD * Eric M. Leibert MD NYU Medical Center, New York, NY

COPYRIGHT 2005 American College of Chest Physicians
COPYRIGHT 2005 Gale Group

Return to Levaquin
Home Contact Resources Exchange Links ebay